Bayesian Capital Management’s Pfizer PFE Stock Holding History

Bayesian Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-46,700	Closed	-$1.31M	–	287
2026 Q1	$1.31M	Buy	+46,700	New	+$1.24M	1.6%	14
2025 Q3	–	Sell	-98,200	Closed	-$2.38M	–	743
2025 Q2	$2.38M	Sell	98,200 -55,000	-36%	-$1.28M	0.38%	71
2025 Q1	$3.88M	Sell	153,200 -28,400	-16%	-$743K	0.64%	28
2024 Q4	$4.82M	Buy	181,600 +40,800	+29%	+$1.11M	0.59%	28
2024 Q3	$4.07M	Buy	140,800 +85,700	+156%	+$2.5M	0.48%	42
2024 Q2	$1.54M	Sell	55,100 -164,900	-75%	-$4.54M	0.18%	155
2024 Q1	$6.11M	Buy	220,000 +44,800	+26%	+$1.24M	0.58%	31
2023 Q4	$5.04M	Buy	175,200 +63,600	+57%	+$1.92M	0.54%	33
2023 Q3	$3.7M	Buy	111,600 +51,300	+85%	+$1.81M	0.42%	56
2023 Q2	$2.21M	Buy	60,300 +35,800	+146%	+$1.39M	0.24%	108
2023 Q1	$1,000K	Buy	+24,500	New	+$1.06M	0.12%	236
2022 Q3	–	Sell	-18,400	Closed	-$965K	–	949
2022 Q2	$965K	Buy	+18,400	New	+$938K	0.18%	162
2022 Q1	–	Sell	-6,000	Closed	-$354K	–	887
2021 Q4	$354K	Sell	6,000 -28,900	-83%	-$1.43M	0.11%	237
2021 Q3	$1.5M	Sell	34,900 -800	-2%	-$35.4K	0.43%	56
2021 Q2	$1.4M	Sell	35,700 -60,644	-63%	-$2.36M	0.37%	74
2021 Q1	$3.49M	Buy	96,344 +47,644	+98%	+$1.69M	0.8%	20
2020 Q4	$1.79M	Buy	+48,700	New	+$1.79M	0.47%	51
2020 Q2	–	Sell	-90,012	Closed	-$2.79M	–	720
2020 Q1	$2.79M	Buy	+90,012	New	+$3.07M	0.6%	17
2016 Q3	–	Sell	-25,612	Closed	-$856K	–	464
2016 Q2	$856K	Buy	+25,612	New	+$817K	0.51%	34

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bayesian Capital Management's PFE Position: Q2 2026 in Review

Bayesian Capital Management sold out of Pfizer (PFE) in Q2 2026, closing a stake of 46,700 shares — an estimated $1.31M sold.

Bayesian Capital Management first reported a position in PFE in Q2 2016 and held it in 19 quarters. The position peaked at $6.11M in Q1 2024. 2,820 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Bayesian Capital Management reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
Bayesian Capital Management sold 46,700 Pfizer shares in Q2 2026, an estimated $1.31M.
Bayesian Capital Management first reported a position in Pfizer in Q2 2016 and held it in 19 quarters.
Bayesian Capital Management's Pfizer position peaked at $6.11M in Q1 2024.
2,820 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Bayesian Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.